Dorsey & Whitney Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Dorsey & Whitney Trust’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$443K	Hold	2,800	–	–	0.02%	474
2026 Q1	$358K	Hold	2,800	–	–	0.02%	514
2025 Q4	$341K	Hold	2,800	–	–	0.02%	520
2025 Q3	$281K	Hold	2,800	–	–	0.01%	555
2025 Q2	$232K	Hold	2,800	–	–	0.01%	601
2025 Q1	$227K	Hold	2,800	–	–	0.01%	604
2024 Q4	$252K	Buy	2,800 +600	+27%	+$58.1K	0.01%	579
2024 Q3	$217K	Hold	2,200	–	–	0.01%	627
2024 Q2	$204K	Buy	+2,200	New	+$197K	0.01%	595

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Dorsey & Whitney Trust's XBI Position: Q2 2026 in Review

Dorsey & Whitney Trust held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 2,800 shares worth $443K. The position accounts for 0.02% of the portfolio, ranked #474.

Dorsey & Whitney Trust first reported a position in XBI in Q2 2024 and has held it in 9 quarters since. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Dorsey & Whitney Trust held 2,800 shares of State Street SPDR S&P Biotech ETF worth $443K as of Q2 2026.
Dorsey & Whitney Trust left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.02% of Dorsey & Whitney Trust's portfolio in Q2 2026, its #474 holding.
Dorsey & Whitney Trust first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and has held it in 9 quarters since.
936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q2 2026, filed 14 Aug 2026.